← All trials
NCT06680128
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 20, 2025
- Primary completion
- Jun 26, 2026
- Completion date
- Mar 19, 2028
- First posted
- Nov 8, 2024
- Last posted
- Nov 8, 2024
- Enrollment
- 402
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Sponsors
- SK Bioscience Co., Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.